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a  b  s  t  r  a  c  t
Background:  Myocardial  thickness  is particularly  thick  at the  ridge  between  the  left  pulmonary  vein  (PV)
and the  left  atrial  appendage  (LAA)  by  dissection.  We  investigated  whether  atrial  ﬁbrillation  (AF)  ablation
outcome  was  inﬂuenced  by altering  ablation  strategies  according  to the  thickness  of the  PV–LAA ridge
using  preprocedural  multidetector  computed  tomography  (MDCT).
Methods  and results:  Patients  with  AF  scheduled  for extensive  encircling  circumferential  pulmonary  vein
isolation  (EEPVI)  (110  patients)  were  divided  into  2  groups.  In  the  nonmodulation  group  (32  patients),
EEPVI  lines  were  created  using  a 3.5-mm  tip  irrigated  catheter  at a maximum  power  of 30 W  for  20–30  s
at each  site.  In  the  modulation  group  (78 patients),  ablation  was  extended  (40–60  s)  at the  PV–LAA ridge
if  its thickness  was  >4.0 mm  on  MDCT  examination.  Extended  ablation  at the  PV–LAA  ridge  was  noted  in
37  patients  in the  modulation  group.  During  25  ±  9  months  of follow-up,  recurrence  was  signiﬁcantly  less
in the  modulation  group  than  in the  nonmodulation  group  (10%  vs. 28%;  p  =  0.018).  Logistic  regression
analysis  showed  that  modiﬁcations  in the  ablation  time  and  left atrium  volume  index  were  independent
predictors  of arrhythmia-free  recovery  after  ablation.
Conclusions:  Recurrence  following  EEPVI  could  be reduced  by modiﬁcations  in the  ablation  time at  the
PV–LAA  ridge.
©  2012  Japanese  College  of Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.. Introduction
Radiofrequency (RF) catheter ablation has emerged as an impor-
ant treatment option for patients with atrial ﬁbrillation (AF).
owever, a wide variation in success rates after catheter abla-
ion has been reported, and AF recurrence remains an important
roblem.
Arrhythmia recurrence after AF ablation is often associated with
ulmonary vein (PV) reconnection [1,2]. In particular, the ridge
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ttp://dx.doi.org/10.1016/j.jjcc.2012.03.007between the left PV oriﬁces and the os of the left atrial appendage
(LAA) is a location where conduction recurs easily [3]. Electro-
physiologists have recognized the presence of several endocardial
ridges that may  make catheter positioning for ablation difﬁcult in
this region, resulting in incomplete ablation lines [4–6]. The most
prominent ridge in the left atrium (LA) is the PV–LAA ridge [5]. In
addition, myocardial thickness varies among different regions in
the heart, and the myocardial thickness at the PV–LAA ridge is par-
ticularly thick when examined by dissection [7,8], indicating that
the creation of transmural lesions in this section may be difﬁcult in
some patients.We  examined LA thickness preprocedurally by multidetector
computed tomography (MDCT) and investigated whether modify-
ing the ablation strategies according to the thickness of the PV–LAA
ridge could decrease AF recurrence.
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. Methods
.1. Study population
This study included 110 consecutive patients who  underwent
heir ﬁrst AF ablation for drug-refractory symptomatic AF (89
en  and 21 women; mean age 60 ± 11 years; range 25–77 years).
atients were randomly assigned in a 1:2 sequential fashion into
 groups receiving different PV–LAA ridge ablation therapies. In
he nonmodulation group (NM group, 32 patients), RF energy was
elivered for 20–30 s at each point, whereas in the modulation
roup (M group, 78 patients), it was prolonged to 40–60 s at the
V–LAA ridge if its thickness was >4.0 mm on preprocedural MDCT
xamination. Written informed consent for the ablation and ran-
omization was obtained from each patient.
.2. Electrophysiological study and radiofrequency ablation
Transesophageal echocardiography was performed within 24 h
f the ablation procedure to exclude LA thrombus. Antiarrhythmic
rugs were discontinued ≥5 half-lives before the electrophysi-
logical study, except for amiodarone, which was  discontinued
4 weeks prior to the study. All patients received anticoagulants
or >1 month. We  performed extensive encircling pulmonary vein
solation (EEPVI) guided by 2 circular mapping catheters (Lasso;
iosense Webster, Diamond Bar, CA, USA) and electroanatom-
cal mapping (CARTO; Biosense Webster) with CT integration
CARTOMERGETM; Biosense Webster).
.3. MDCT angiography
CT examinations were performed using a 64-slice CT scanner
LightSpeed VCT; GE Healthcare, Waukesha, WI,  USA). The precise
can protocol of the retrospective electrocardiogram-gated scan
as been previously described [9].  Raw scan data were transferred
o a computer workstation, where the images were reconstructed
Virtual Place Advance; AZE Inc., Tokyo, Japan) and analyzed in a
linded fashion. During image acquisition in patients with a sinus
hythm, the phase corresponding with end-diastole of the atria, just
efore mitral valve opening, was selected for evaluation [10]. Dur-
ng image acquisition in patients with AF, the phase that appeared
o have the largest LA volume was selected for assessment.
First, the LA volume was calculated as described in previous CT
maging studies [11]. For the biplane area-length method, maxi-
al  area was measured with a planimeter for 4- and 2-chambered
iews by tracing the endocardial border, excluding the conﬂuence
f the pulmonary veins and LA appendage, and the length was
easured from the midline of the mitral annulus plane to the
ig. 1. Thickness of the ridge (two-headed arrow) between the left pulmonary vein (LPV) or
mage  generated from an axial source image (left panel) by multidetector computed tomo
o  be epicardial organization. LA, left atrium.ology 60 (2012) 236–241 237
opposite superior aspect of the left atrium. LA volume was
calculated using the following formula: 0.85 × 4-chamber area × 2-
chamber area/average of the 2 lengths.
Next, LA wall thickness was  measured in preselected locations
on the EEPVI line at their thickest points, using cross-sectional
sources and orthogonal to the source images. Wall thickness was
measured from the density of the intracavitary contrast medium
that ﬁlled the PV and LA, and epicardial organization was  identi-
ﬁed by an abrupt change in signal density. The measured points
were as follows: the superior sites of the LA at 5–10 mm apart from
each superior PV ostium, and the inferior sites of the LA at 5–10 mm
apart from each inferior PV ostium, the PV–LAA ridge, and the roof,
ﬂoor, and posterior walls of the LA (Fig. 1).
2.4. Catheter ablation
A 6F decapolar catheter (St. Jude Medical, St. Paul, MN,  USA)
was positioned in the coronary sinus for pacing and recording. A
transeptal puncture was performed, and intravenous heparin was
administered to maintain an activated clotting time of 300–350 s.
EEPVI was  performed to electrically isolate the left and right PVs in
pairs at 5–20 mm from their ostia [12,13]. Ablation was  attempted
along the PV–LAA ridge at the anterior part of the left PV and was
performed with an irrigated 3.5-mm tip electrode catheter (THER-
MOCOOL; Biosense Webster). The ﬂow rate was  17–30 mL/min,
energy settings were 25–35 W,  and temperatures were 40–45 ◦C.
In the NM group, RF energy was delivered for 20–30 s at each point
around the EEPVI line. In the M group, ablation time was extended
to 40–60 s at the PV–LAA ridge if its thickness was >4.0 mm  on
preprocedural MDCT examination. Ablation was  performed during
baseline rhythm with no attempt to perform pharmacological or
direct current cardioversion. The EEPVI endpoint was the creation
of a bidirectional conduction block from the atrium to the PVs. If
AF was  still detected after completion of the EEPVI line, transtho-
racic cardioversion was  performed to restore sinus rhythm. After
completing the EEPVI, each vein was  rechecked for isolation after
≥30-min waiting period. Following EEPVI, the cavotricuspid isth-
mus  line was ablated, with the endpoint being a bidirectional
conduction block [14].
2.5. Post-ablation management
All patients were followed up for at least 12 months. Follow-up
consisted of outpatient visits, and 12-lead and 24-h Holter mon-
itoring at 1, 3, and 6 months, and every 6 months thereafter if
the patient remained asymptomatic. Patients were also asked to
report any arrhythmia symptoms that occurred between sched-
uled visits. Recurrent AF was  diagnosed when (1) patients reported
iﬁces and the os of the left atrial appendage (LAA) from a multiplanar reconstruction
graphy. We selected the view that did not include the low intensity area considered







































Completion of PV–LA block
on the ﬁrst EEPVI line
10 (31%) 31 (40%) 0.40
Additional RF duration on
the PV–LAA ridge, s
33.5 ± 39.5 11.3 ± 20.6 0.0002
Total RF duration on the
PV–LAA ridge, s
197.8 ± 46.8 190.7 ± 52.3 0.65
Total RF energy on the
PV–LAA ridge, J
5934 ± 1403 5720 ± 1568 0.6538 Y. Makita et al. / Journal o
ymptoms suggestive of tachycardia, and (2) a >30-s episode of
F was recorded on 12-lead or 24-h Holter monitoring. Early AF
ecurrences (within 3 months after ablation) were not considered
or data analysis because these episodes are often transient phe-
omena reﬂecting a reverse remodeling process [15]. All patients
ontinued oral anticoagulation medication to maintain an inter-
ational normalized ratio of 2.0–3.0 for a minimum of 3 months.
ntiarrhythmic drugs were discontinued 2 months after the abla-
ion procedure. The primary endpoint of the study was freedom
rom recurrence of AF after the initial ablation procedures.
.6. Statistical analysis
Categorical variables are expressed as numbers and per-
entages. Continuous data are presented as means ± standard
eviations. Continuous and categorical variables were compared by
tudent’s t-test and chi-square test, respectively. A Kaplan–Meier
nalysis was used to determine the percentage of patients free of
F after the initial procedure, and any differences in the AF-free
urvival were evaluated using the log-rank test. Univariate and
ultivariate logistic regression analyses were performed to iden-
ify the predictors of AF recurrence after the ablation procedure.
-values < 0.05 were considered statistically signiﬁcant.
. Results
.1. Clinical characteristics
No signiﬁcant differences were observed between patients of
he NM and M groups in baseline clinical characteristics, includ-
ng AF duration, the presence of hypertension or structural heart
isease, LA diameter, or left ventricular ejection fraction (Table 1).
able 1








Age, years 61 ± 11 60 ± 11 0.56
Male sex 27 (84%) 62 (79%) 0.55
Body mass index, kg/m2 23.9 ± 2.5 23.1 ± 2.6 0.12
Duration of AF, years 6.0 ± 4.4 4.7 ± 4.6 0.17
Antiarrhythmic drugs 25 (78%) 50 (64%) 0.14
Amiodarone 1 (3%) 8 (10%) 0.22
ACEI/ARB 11 (34%) 19 (24%) 0.29
Hypertension 16 (50%) 38 (49%) 0.90
Diabetes 2 (6%) 9 (12%) 0.40
Structural heart disease 5 (16%) 15 (19%) 0.65
LA diameter, mm 39.8 ± 7.5 39.0 ± 6.9 0.60
Left ventricular ejection
fraction, %
62.5 ± 10.4 63.7 ± 8.6 0.56
MDCT parameters
PV–LAA ridge, mm 4.3 ± 1.4 4.1 ± 1.0 0.34
Left superior site, mm 2.1 ± 0.3 2.1 ± 0.3 0.85
Left inferior site, mm 1.7 ± 0.3 1.7 ± 0.3 0.78
Right superior site, mm 2.0 ± 0.3 2.0 ± 0.3 0.90
Right inferior site, mm 2.0 ± 0.4 1.9 ± 0.4 0.41
Roof, mm 3.0 ± 0.6 2.8 ± 0.7 0.29
Floor, mm 2.5 ± 0.5 2.4 ± 0.5 0.72
Posterior, mm 2.0 ± 0.3 2.0 ± 0.4 0.47
LA volume index,
ml/kg/m2
35.6 ± 10.4 37.9 ± 14.8 0.44
esults are presented as mean ± SD. AF: atrial ﬁbrillation; LA: left atrial; LAA: left
trial appendage; MDCT: multidetector computed tomography; M:  modulation;
M:  nonmodulation; PV: pulmonary vein.Results are presented as mean ± SD. EEPVI: extensive encircling circumferential pul-
monary vein isolation; NM:  nonmodulation; M:  modulation; PV: pulmonary vein;
LA: left atrial; RF: radiofrequency; LAA: left atrial appendage.
3.2. MDCT parameters
In this study, the PV–LAA ridge was  the thickest of all measured
regions, with a median thickness of 4.0 mm.  No signiﬁcant differ-
ences were found between the NM and M groups for the MDCT
parameters, including mean wall thickness or LA volume index
(Table 1).
3.3. Catheter ablation outcome
The EEPVI endpoint was  achieved in all patients. The PV–LAA
ridge was thicker than 4.0 mm in 37 cases (47%) of the M group and
we extended ablation time in these cases. The ratio of patients in
whom a complete bidirectional conduction block from the PVs to
the atrium by the ﬁrst line was  achieved was similar in both groups
(31% in the NM group vs. 40% in the M group; p = 0.40). The applica-
tion duration and delivered RF energy at the PV–LAA ridge were not
signiﬁcantly different between both groups. The duration of addi-
tional RF on the PV–LAA ridge to achieve complete bidirectional
conduction block was  longer in the NM group than in the M group
(33.5 ± 39.5 s vs. 11.3 ± 20.6 s, respectively; p = 0.0002) (Table 2).
At the last follow-up (25 ± 9 months), 93 of the 110 patients
(85%) were free of AF. Beyond a blanking period of 3 months, the
AF-free rate at 12 months after a single ablation was  signiﬁcantly
higher in the M group compared to the NM group (70 patients [90%]
vs. 23 patients [72%], respectively; p = 0.018).
3.4. Second ablation procedure
In a total of 17 AF recurrence patients, 7 patients (NM group, 4; M
group, 3) underwent a second ablation procedure. The remaining
10 patients did not wish to undergo a second procedure because
of the signiﬁcant reduction in arrhythmia burden after the ﬁrst
ablation. All but 1 patient in the recurrence patients exhibited
reconnection of the PVs (86%). During the second ablation, a mean
of 2.4 ± 1.3 PVs were reconnected. Left PV (LPV) reconnection was
seen in the PV–LAA ridge (6 patients), posterior wall (1 patient),
superior site (1 patient), inferior site (3 patients), and the carina
region (1 patient). Right PV (RPV) reconnection was seen in the
posterior wall (4 patients), superior site (2 patients), inferior site
(2 patients), and the carina region (2 patients). In NM group, in all
patients PV–LAA ridge was  reconnected.
3.5. Predictors of atrial ﬁbrillation recurrence
Univariate and multivariate analyses were performed to identify
whether the modiﬁcation of the procedure based on LA thick-
ness quantiﬁed by preprocedural MDCT examination predicted AF
recurrence (Table 3). Patients were divided into groups based on
outcome: those with clinical success and those with AF recurrences
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Table  3
Univariate and multivariate logistic regression analyses for predictors of recurrence of atrial ﬁbrillation.
Univariate analysis Multivariate analysis
OR (95%CI) p-Value OR (95%CI) p-Value
Age 1.00 (0.95–1.05) 0.99
Male sex 1.06 (0.57–2.29) 0.87
Body mass index 1.08 (0.88–1.32) 0.48
Duration of AF 1.06 (0.95–1.17) 0.26
Hypertension 3.04 (1.04–10.2) 0.052
Diabetes 1.24 (0.18–5.45) 0.79
Structural heart disease 2.17 (0.62–6.83) 0.20
LA  diameter 1.10 (1.02–1.19) 0.020
Left  ventricular ejection fraction 1.00 (0.95–1.06) 0.87
Thickness of the PV–LAA ridge 1.57 (1.02–2.45) 0.041 1.76 (0.97–3.43) 0.072
Thickness of the left superior site 0.46 (0.06–2.76) 0.42
Thickness of the left inferior site 1.11 (0.16–7.23) 0.91
Thickness of the right superior site 0.89 (0.19–4.40) 0.89
Thickness of the right inferior site 1.02 (0.27–3.75) 0.97
Thickness of the roof 0.84 (0.35–1.89) 0.67
Thickness of the ﬂoor 0.82 (0.28–2.19) 0.71
Thickness of the posterior 1.32 (0.32–5.42) 0.70
LA  volume index 1.09 (1.04–1.14) 0.0005 1.13 (1.07–1.23) 0.0003
0.023 0.083 (0.013–0.39) 0.0032













































Age, years 59 ± 11 63 ± 9 0.25
Male sex 9 (82%) 33 (80%) 0.92
Body mass index, kg/m2 23.1 ± 3.1 23.6 ± 2.6 0.46
Duration of AF, years 6.6 ± 5.3 4.1 ± 3.7 0.094
Hypertension 8 (73%) 29 (71%) 0.90
Diabetes 1 (9%) 4 (10%) 0.95
Structural heart disease 3 (27%) 4 (10%) 0.15
LA diameter, mm 42.8 ± 6.7 39.4 ± 5.0 0.077
Left ventricular ejection
fraction, %
63.3 ± 11.3 64.2 ± 8.6 0.77
MDCT parameters
PV–LAA ridge, mm 5.3 ± 1.3 5.0 ± 0.8 0.28
Left superior site, mm 2.0 ± 0.2 2.1 ± 0.3 0.39
Left inferior site, mm 1.8 ± 0.3 1.7 ± 0.3 0.49
Right superior site, mm 2.1 ± 0.2 2.1 ± 0.3 0.64
Right inferior site, mm 2.0 ± 0.3 1.9 ± 0.4 0.57
Roof, mm 2.9 ± 0.5 2.9 ± 0.7 0.88
Floor, mm 2.4 ± 0.4 2.5 ± 0.5 0.67
Posterior, mm 1.9 ± 0.2 2.0 ± 0.4 0.15
volume index, ml/kg/m2 49.4 ± 16.8 36.8 ± 11.0 0.015
Modiﬁcation 4 (36%) 33 (80%) 0.0076
Multivariate analysis
OR 95%CI p-Value
LA volume index 1.14 1.05–1.28 0.0069
Modiﬁcation 0.027 0.0013–0.23 0.0048
Results are presented as mean ± SD. AF: atrial ﬁbrillation; LA: left atrium;Modiﬁcation 0.29 (0.099–0.85)
esults are presented as mean ± SD. CI: conﬁdence interval; OR: odds ratio; AF: atri
ollowing catheter ablation. Predictors of AF recurrence follow-
ng catheter ablation by the univariate analysis were LA diameter
p = 0.020), thickness of the PV–LAA ridge (p = 0.041), LA volume
ndex (p = 0.0005), and modiﬁcation (p = 0.023). Multivariate anal-
sis using the thickness of the PV–LAA ridge, LA volume index,
nd modiﬁcation revealed that the LA volume index [odds ratio
OR), 1.13; 95% conﬁdence interval (CI), 1.07–1.23; p = 0.0003) and
odiﬁcation (OR, 0.083; 95% CI, 0.013–0.39; p = 0.0032) remained
igniﬁcantly and independently associated with AF recurrence.
.6. Comparison of results in patients with thick ridges
Of the 110 patients, there were 52 (47%) with PV–LAA ridge
hickness >4.0 mm.  The application duration was  prolonged at the
V–LAA ridge in 37 of these patients and RF energy was delivered
or the same duration at each point in the remaining 15 patients.
AF recurrence occurred in 11 of the 52 patients. In these patients
ith AF recurrence, the percentage of patients with modiﬁed RF
pplication was signiﬁcantly lower and the LA volume index was
igniﬁcantly greater (Table 4) than those in the non-recurrence
atients. A Kaplan–Meier survival analysis showed that the AF-free
ate during 12-month follow-up periods after a single ablation was
igniﬁcantly higher in the M group compared to the NM group
mong the patients with thick ridges [33 patients (89%) vs. 8
atients (53%), respectively; p = 0.003 by the log-rank test; Fig. 2].
. Discussion
This study produced several ﬁndings. Firstly, there is regional
ariability in LA wall thickness and that the PV–LAA ridge is the
hickest region of all regions quantiﬁed in this study. Secondly, the
F recurrence rate is lower in patients whose RF duration was  mod-
ﬁed based on the PV–LAA ridge thickness. Thirdly, few patients
nderwent a second ablation procedure, and the reconnection was
een most commonly around the PV–LAA ridge and posterior wall
f the RPV. Fourthly, modiﬁcation of the procedure and the LA vol-
me  index remained signiﬁcantly and independently associated
ith AF recurrence. Our ﬁndings have potential clinical implica-
ions in the determination of appropriate ablation strategy. Longer
esions may  be required in thicker areas, particularly at the PV–LAA
idge, in order to achieve transmural lesions.
Arrhythmia recurrence following AF ablation is often associ-
ted with pulmonary vein reconnection [1,2]. A repeat procedureMDCT: multidetector computed tomography; PV: pulmonary vein; LAA: left atrial
appendage.
consisting of reisolation of the recovered veins further eliminates
AF and improves clinical outcomes [16,17]. The PV–LAA ridge, a fold
of the lateral LA wall protruding into the endocardial LA surface, is
recognized as a section where conduction commonly recurs [3].  Its
shape and size is relevant during AF catheter ablation when it encir-
cles the LPV oriﬁces. Anatomical information can be obtained with
current MDCT and magnetic resonance imaging reconstructions of
the endocardial aspect of LA [4–6]. The width of the PV–LAA ridge
measures 5–6 mm  on average. A narrow ridge in some patients
can make it technically difﬁcult to stabilize a catheter directly on
these folds during ablation; hence, it may  be challenging to obtain
a complete circumferential ablation line at this site [18].
240 Y. Makita et al. / Journal of Cardi
Fig. 2. Kaplan–Meier curves for maintaining sinus rhythm in patients with thick
pulmonary vein-left atrial appendage ridge after a single ablation procedure. Signif-













































Ujino K, Hozumi T, Yoshiyama M.  Comparison of determinations of left atrialhe  modulation and the nonmodulation groups. A blanking period of 3 months was
pplied.
In addition, it has been reported that myocardial thickness at
he PV–LAA ridge is particularly thick when examined by dis-
ection [7,8]. The myocardial thickness of PVs is thickest at the
enoatrial junction with a mean thickness of 1.1 ± 0.4 mm;  the
hickness tapers toward the lung hila. In contrast, the myocar-
ial thickness of the PV–LAA ridge is 1.7 ± 0.8 mm at the inferior
evel and 2.8 ± 1.1 mm at the superior level. The width of the
V–LAA ridge, including the non-myocardial components, is
.6 ± 0.4 mm at the superior level and 10.2 ± 0.5 mm at the inferior
evel.
In this study, we measured wall thickness by MDCT examina-
ion and found that the thickness varied at different parts of the
EPVI line. In particular, the PV–LAA ridge was thick, suggesting
hat transmural lesions at the PV–LAA ridge are difﬁcult to achieve
n some patients. The ratio of patients in whom a complete bidirec-
ional conduction block from the PVs to the atrium was  achieved
as similar whether the RF time on the PV–LAA ridge was (M group)
r was not (NM group) prolonged during the ﬁrst linear EEPVI. How-
ver, after we ended the ﬁrst linear ablation, more in the NM group
equired additional RF on the PV–LAA ridge than in the M group
o achieve a complete block between PV and LA. This resulted in
fﬁcient and effective elongation of RF time on the PV–LAA ridge
hen we ablated the ﬁrst EEPVI line. We  were able to improve the
rognosis of patients with a prolonged ablation time at the PV–LAA
idge. These factors, in combination with the technical difﬁculties
n catheter stability, highlight the importance of these sites in AF
blation and PV isolation.
Moreover, LA volume index was also a predictor of AF recur-
ence after catheter ablation in this study. Studies have examined
he relationship between LA volume and the outcome of AF abla-
ion, and demonstrated that LA volume is an independent predictor
f outcome following AF ablation [19–24].  Helms et al. attempted
o explain this observation, stating that (1) electrical reconnection
f PVs is more likely in patients with larger LA and/or (2) struc-
ural remodeling within a very enlarged LA is so extensive that the
blation lesions do not sufﬁciently modify the atrial substrate. Bet-
er techniques for creating continuous ablation lines with no gaps
etween lesions may  help, but the number and location of these
ines remain to be determined [25]. Alternatively, additional abla-
ion techniques to modify the substrate, such as ablation guided
y complex fractionated electrograms [26], identifying and ablat-
ng ganglionated plexuses, or epicardial foci, may  be beneﬁcial in
hese patients.
[ology 60 (2012) 236–241
5.  Conclusions
Preprocedural MDCT examinations revealed varying thickness
on parts of the EEPVI line, and that the PV–LAA ridge was partic-
ularly thick. Catheter ablation along this aspect may  be associated
with difﬁculty in achieving transmural lesions, suggesting that con-
trolled ablation in terms of duration along this area may  decrease
AF recurrence after EEPVI.
6. Limitations
Our study had several limitations. Firstly, this study was  per-
formed with a relatively small number of patients and had a short
follow-up period. Secondly, we conducted MDCT examinations
before the procedure, meaning that the RF location may  not nec-
essarily agree with the location measured by MDCT examination.
Thirdly, we did not seek to identify triggers at the initial procedure.
In addition, some patients did not undergo a second procedure,
and we  therefore could not evaluate the cause of AF recurrence,
the reconnection of PV–LA conduction or the contribution of non-
PV foci in these patients. Fourthly, the PV–LAA ridge contains not
only myocardium but also non-muscular tissues such as nerves and
vessels. We  cannot completely eliminate these factors through the
performance of MDCT. Fifthly, the resolution of 64-slice MDCT used
in this study can recognize minimum 0.625 mm resolution ability
and the measured thickness value using the MDCT has an accuracy
within a range of 0.625 mm.  Finally, the mechanism for the variabil-
ity in the thickness of the PV–LAA ridge remains unclear because
we did not conduct a histopathological examination.
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